Comparative proteome analysis of Brucella melitensis vaccine strain Rev 1 and a virulent strain, 16M
about
Proteomics for biodefense applications: progress and opportunities.Comparative secretome analyses of three Bacillus anthracis strains with variant plasmid contents.Quantitative analysis of representative proteome components and clustering of Helicobacter pylori clinical strains.Complete genome-wide screening and subtractive genomic approach revealed new virulence factors, potential drug targets against bio-war pathogen Brucella melitensis 16M.Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.Comparative genomic analysis between newly sequenced Brucella suis Vaccine Strain S2 and the Virulent Brucella suis Strain 1330Comprehensive Identification of Immunodominant Proteins of Brucella abortus and Brucella melitensis Using Antibodies in the Sera from Naturally Infected Hosts.Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge.Identification of immunoreactive proteins of Brucella melitensis by immunoproteomics.Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.Antimicrobial susceptibility of Brucella melitensis in Kazakhstan.Immunoproteomics of Brucella abortus reveals differential antibody profiles between S19-vaccinated and naturally infected cattleGenomic analysis of the original Elberg Brucella melitensis Rev.1 vaccine strain reveals insights into virulence attenuation
P2860
Q33215043-70D4790A-C50B-4F2B-BC54-6786992CEA02Q33215553-413FC8E4-29A2-49EF-A8B8-57E08FB3A1B6Q33262632-075C864C-29A1-4014-8E86-17A753F46A5EQ35212443-791C202E-B2B7-479B-AFB8-EE10A2DA31E7Q35987800-38FDC57C-667C-4683-A493-EFD9F200433FQ36137471-AFBA3710-2E31-4122-9ADA-C961FFF8F022Q36939167-E3DF265B-1835-4505-BCC1-031143E43A3DQ41761576-0E322B33-1DD8-45E0-91C1-5719A1945B1FQ43943687-F717AFE9-A4DF-4C70-9450-6DD3D7632E3AQ44495491-D286EB3B-86AE-4D66-B38D-B50010C420FDQ47099367-7FDB8A8F-8661-4DAE-8D35-436C60768B89Q58438919-0F129866-A39C-4720-B7D6-48EB139600CFQ58764543-E3F620BB-8DAC-43EE-92F8-640FF1437F8C
P2860
Comparative proteome analysis of Brucella melitensis vaccine strain Rev 1 and a virulent strain, 16M
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Comparative proteome analysis ...... v 1 and a virulent strain, 16M
@ast
Comparative proteome analysis ...... v 1 and a virulent strain, 16M
@en
type
label
Comparative proteome analysis ...... v 1 and a virulent strain, 16M
@ast
Comparative proteome analysis ...... v 1 and a virulent strain, 16M
@en
prefLabel
Comparative proteome analysis ...... v 1 and a virulent strain, 16M
@ast
Comparative proteome analysis ...... v 1 and a virulent strain, 16M
@en
P2093
P2860
P1476
Comparative proteome analysis ...... v 1 and a virulent strain, 16M
@en
P2093
Cesar V Mujer
Jo Ann Kraycer
Mary Ann Wagner
Michel Eschenbrenner
Philip Elzer
Sue Hagius
Troy A Horn
Vito G DelVecchio
P2860
P304
P356
10.1128/JB.184.18.4962-4970.2002
P407
P577
2002-09-01T00:00:00Z